Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical and phase I data presented for AP-26113

Nov. 30, 2012

MM-938 significantly reduces tumor growth rates in glioblastoma mouse models

Nov. 30, 2012

First-in-human study of AT-406 described

Nov. 30, 2012

RVX-297 reduces clinical signs of disease in a rat model of rheumatoid arthritis

Nov. 30, 2012

PAX2 identified in CNS hemangioblastomas

Nov. 30, 2012

Proof-of-concept results reported for BAY-94-8862

Nov. 30, 2012

First clinical data on RG-7212 show target modulation and signs of efficacy

Nov. 29, 2012

Safety and pharmacokinetic phase I data reported for MGL-3196

Nov. 29, 2012

APY-0201 significantly ameliorates skin inflammation in animal models of psoriasis

Nov. 29, 2012

Phase I and II data reveal efficacy of AMG-145

Nov. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...